WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 9'8001 Infant (under 12 months) mortality rate: 62
GDP / capita (US$): 17'1431 Child (under 5 years) mortality rate: 72

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 29'240  28'759  28'276  27'790  27'302  23'421  18'211  13'834 
Births 516  507  499  491  485  529  514  408 
Surviving infants 514  505  497  489  482  525  507  398 
Pop. less than 5 years 2'425  2'392  2'427  2'433  2'462  2'721  2'446  1'867 
Pop. less than 15 years 7'752  7'769  7'828  7'837  7'852  7'803  6'756  5'394 
Female 15-49 years 8'519  8'368  8'190  8'001  7'802  6'220  4'621  3'458 

Number of reported case

(Click for retrospective incidence data for Malaysia)
Diphtheria 131 
Japanese encephalitis 22  12  17 
Measles 1'868  1'569  73  153  334  6'187  563  8'727 
Mumps
Pertussis 217  248  41  11  42  24  97 
Polio*
Rubella 789  374  104 
Rubella (CRS)
Tetanus (neonatal) 10  13  20  11  60 
Tetanus (total) 34  11  28  19  29  40  30  60 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Malaysia)
Vaccine year result method % card seen                                                
BCG          99  99  98  98  98  100  99  94 
DTP1          95  95  95  95  96  95  95 
DTP3          99  95  95  95  96  95  90  67 
HepB_BD          95  95  95  99  92 
HepB3          98  95  95  95  95  94  86 
Hib3          99  95  95  95  95 
JapEnc          97  96  95  99 
MCV          95  95  95  95  94  88  70 
MCV2          99  95  95  95 
PCV1         
PCV3         
Pol3          100  95  95  95  96  95  90  67 
Rota1         
Rota_last         
Rubella1          95  95  95 
TT2plus          90  80  75  77  76  89  82  22 
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Malaysia)
BCG 99  99  99  98  98  99  99  94 
DTP1 99  99  98  95  96  95  95  86 
DTP3 99  99  94  95  96  95  90  67 
HepB3 98  97  96  95  95  94  86 
Hib3 99  99  94  95  95 
MCV 95  95  96  95  94  88  70 
PAB 90  90  87  87  87  88  82  20 
PCV3
Pol3 99  99  94  95  96  95  90  67 
Rota_last

Number of districts in the country 142  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 73
From 80 to 89% 20
From 50 to 79% 8
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DT 7 years; Yes
DTaPHibIPV 2, 3, 5, 18 months; Yes
HPV 13 years (x3); Yes Girls only
HepB birth; 1, 6 months; Yes and HCWs
JapEnc 9, 10, 18 months; 5, 8, 11 years; No
MMR 1 year; Yes
MR 7 years; Yes
Measles 6 months; No
OPV 7 years; Yes
TT 15 years; Yes pregnant women
Tdap 15 years; Yes
Typhoid Yes food handlers
YF travelers to endemic countries

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR No  No  No  No  No  Yes  No 
What years does the MYP cover? number           2006-2010  NA 
Nº of districts with microplans that include activities to raise immunization coverage number 142        139  139  132 

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR Yes  Yes  Yes         

System performance

Total number of districts in country number 142  141  141  139  139  139  132 
Nº districts with DTP3 coverage >=80% number 131  125  128  120  136  119   
% of districts with DTP3 coverage >=80% From 0 to 100% 92  89  91  86  98  86   
Nº districts with measles (MCV1) coverage >=95% number 94  72  70  72  94     
% of districts with MCV1 coverage >=95% From 0 to 100% 66  51  50  52  68     

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes         

Finance

Percentage of routine vaccines funded by Government From 0 to 100%   80  80  80  80  100  100 

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.